Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
1
|
pubmed:dateCreated |
1996-8-21
|
pubmed:abstractText |
The apolipoprotein E (apoE) epsilon 4 allele is overrepresented, and the apoE epsilon 2 allele underrepresented, in Alzheimer's disease. To assess the risk of cognitive impairment in individuals with these genotypes in the general population, we studied a population-based sample of 1,899 individuals 65 years and older as a follow-up to the Iowa 65+ Rural Health Study. Multiple regression and logistic regression analyses demonstrated significant effects of apoE epsilon 4 and apoE epsilon 2 in predicting performance on a delayed recall task over a 4- to 7-year period. The magnitude of this effect was, however, fairly modest, with odds ratios for developing impairment of approximately 1.37 (95% confidence interval: 1.007, 1.850; p = 0.045) for apoE epsilon 4 and 0.53 (95% confidence interval: 0.368, 0.777; p = 0.001) for apoE epsilon 2. These effects were more pronounced in women than men. Importantly, 85% of elderly apoE E4/4 individuals (average age, 81) scored in the unimpaired range on a screening mental status test. Thus, many individuals reach old age without cognitive impair- ment despite inheritance of one or two apoE epsilon 4 alleles. This suggests that apoE genotyping will have limited utility as a diagnostic or prognostic indicator of cognitive decline in individuals.
|
pubmed:grant | |
pubmed:commentsCorrections | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Jul
|
pubmed:issn |
0364-5134
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
40
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
55-66
|
pubmed:dateRevised |
2007-11-14
|
pubmed:meshHeading |
pubmed-meshheading:8687193-Aged,
pubmed-meshheading:8687193-Alleles,
pubmed-meshheading:8687193-Alzheimer Disease,
pubmed-meshheading:8687193-Apolipoproteins E,
pubmed-meshheading:8687193-Brain,
pubmed-meshheading:8687193-Cholesterol, HDL,
pubmed-meshheading:8687193-Cognition Disorders,
pubmed-meshheading:8687193-Cross-Sectional Studies,
pubmed-meshheading:8687193-Female,
pubmed-meshheading:8687193-Genotype,
pubmed-meshheading:8687193-Humans,
pubmed-meshheading:8687193-Longitudinal Studies,
pubmed-meshheading:8687193-Male,
pubmed-meshheading:8687193-Polymerase Chain Reaction,
pubmed-meshheading:8687193-Prospective Studies
|
pubmed:year |
1996
|
pubmed:articleTitle |
Apolipoprotein E and cognitive change in an elderly population.
|
pubmed:affiliation |
Neurology Service, Massachusetts General Hospital, Boston, MA 02114, USA.
|
pubmed:publicationType |
Journal Article,
Comparative Study,
Research Support, U.S. Gov't, P.H.S.,
Research Support, Non-U.S. Gov't
|